Athersys
ATHX
#10558
Rank
โ‚ฌ0.7 M
Marketcap
0,01145ย โ‚ฌ
Share price
-33.50%
Change (1 day)
-99.03%
Change (1 year)

EPS for Athersys (ATHX)

EPS in 2023 (TTM): -1,88ย โ‚ฌ

According to Athersys's latest financial reports the company's current EPS (TTM) is -1,72ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -5,54ย โ‚ฌ a decrease over its 2021 EPS that were of -1,76ย โ‚ฌ.

EPS history for Athersys from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,88ย โ‚ฌ-66.06%
2022-5,54ย โ‚ฌ213.94%
2021-1,76ย โ‚ฌ395.24%
2020-0,36ย โ‚ฌ44.83%
2019-0,25ย โ‚ฌ61.11%
2018-0,15ย โ‚ฌ-37.93%
2017-0,25ย โ‚ฌ70.59%
2016-0,14ย โ‚ฌ-19.05%
2015-0,18ย โ‚ฌ-25%
2014-0,24ย โ‚ฌ
2012-0,42ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
9,44ย โ‚ฌ-648.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,15ย โ‚ฌ-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
12,15ย โ‚ฌ-805.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1,75ย โ‚ฌ-201.73%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
6,20ย โ‚ฌ-459.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,52ย โ‚ฌ-246.31%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
3,87ย โ‚ฌ-324.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-6,84ย โ‚ฌ 297.54%๐Ÿ‡บ๐Ÿ‡ธ USA